{"nct_id":"NCT04295772","title":"Doravirine/Islatravir (DOR/ISL) in Pediatric Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are <18 Years of Age and Weigh ≥35 kg (MK-8591A-028)","status":"COMPLETED","status_verified_date":"2024-01","start_date":"2020-11-26","start_date_type":"ACTUAL","primary_completion_date":"2021-12-21","primary_completion_date_type":"ACTUAL","completion_date":"2023-01-25","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}